These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 19564143

  • 1. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.
    Javadzadeh Y, Mohammadi A, Khoei NS, Nokhodchi A.
    Acta Pharm; 2009 Jun; 59(2):187-97. PubMed ID: 19564143
    [Abstract] [Full Text] [Related]

  • 2. Investigation of intrinsic dissolution behavior of different carbamazepine samples.
    Sehić S, Betz G, Hadzidedić S, El-Arini SK, Leuenberger H.
    Int J Pharm; 2010 Feb 15; 386(1-2):77-90. PubMed ID: 19900519
    [Abstract] [Full Text] [Related]

  • 3. Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique.
    Maghsoodi M.
    Pharm Dev Technol; 2011 Oct 15; 16(5):474-82. PubMed ID: 20557281
    [Abstract] [Full Text] [Related]

  • 4. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
    Rahman Z, Samy R, Sayeed VA, Khan MA.
    Pharm Dev Technol; 2012 Oct 15; 17(4):457-65. PubMed ID: 21265708
    [Abstract] [Full Text] [Related]

  • 5. Crystal growth formation in melt extrudates.
    Bruce C, Fegely KA, Rajabi-Siahboomi AR, McGinity JW.
    Int J Pharm; 2007 Aug 16; 341(1-2):162-72. PubMed ID: 17524578
    [Abstract] [Full Text] [Related]

  • 6. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
    Tran TT, Tran PH, Park JB, Lee BJ.
    Arch Pharm Res; 2012 Jul 16; 35(7):1223-30. PubMed ID: 22864745
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
    Maghsoodi M, Tajalli Bakhsh AS.
    Pharm Dev Technol; 2011 Jun 16; 16(3):243-9. PubMed ID: 20175665
    [Abstract] [Full Text] [Related]

  • 8. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS, Shimpi SL, Paradkar AR.
    Acta Pharm; 2007 Sep 16; 57(3):287-300. PubMed ID: 17878109
    [Abstract] [Full Text] [Related]

  • 9. Crystallization of carbamazepine pseudopolymorphs from nonionic microemulsions.
    Kogan A, Popov I, Uvarov V, Cohen S, Aserin A, Garti N.
    Langmuir; 2008 Feb 05; 24(3):722-33. PubMed ID: 18163657
    [Abstract] [Full Text] [Related]

  • 10. Solid dispersion of acetaminophen and poly(ethylene oxide) prepared by hot-melt mixing.
    Yang M, Wang P, Huang CY, Ku MS, Liu H, Gogos C.
    Int J Pharm; 2010 Aug 16; 395(1-2):53-61. PubMed ID: 20435110
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Glucosamine HCl as a new carrier for improved dissolution behaviour: effect of grinding.
    Al-Hamidi H, Edwards AA, Mohammad MA, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2010 Nov 01; 81(1):96-109. PubMed ID: 20674291
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.
    Rahman Z, Zidan AS, Berendt RT, Khan MA.
    Int J Pharm; 2012 Jan 17; 422(1-2):91-100. PubMed ID: 22037447
    [Abstract] [Full Text] [Related]

  • 17. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
    Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A.
    Int J Pharm; 2007 Aug 16; 341(1-2):26-34. PubMed ID: 17498898
    [Abstract] [Full Text] [Related]

  • 18. Dissolution enhancement of gliclazide using pH change approach in presence of twelve stabilizers with various physico-chemical properties.
    Talari R, Varshosaz J, Mostafavi SA, Nokhodchi A.
    J Pharm Pharm Sci; 2009 Aug 16; 12(3):250-65. PubMed ID: 20067702
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
    Tomaszewska I, Karki S, Shur J, Price R, Fotaki N.
    Int J Pharm; 2013 Sep 10; 453(2):380-8. PubMed ID: 23727143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.